FibroGen
FGEN
FGEN
110 hedge funds and large institutions have $59M invested in FibroGen in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 44 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
71% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 56
72% less capital invested
Capital invested by funds: $208M → $59M (-$149M)
Holders
110
Holding in Top 10
–
Calls
$1.73M
Puts
$56K
Top Buyers
| 1 | +$3.05M | |
| 2 | +$1.39M | |
| 3 | +$1.35M | |
| 4 |
Primecap Management
Pasadena,
California
|
+$904K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$831K |
Top Sellers
| 1 | -$9.06M | |
| 2 | -$6.8M | |
| 3 | -$2.85M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
-$2.65M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$1.96M |